Oceania Healthcare Limited, an ASX-listed company, has released its Interim Report for the six months ended 30 September 2026, showcasing improved underlying business performance. Oceania Healthcare is a New Zealand-based provider of retirement living and aged care services, creating places where older New Zealanders can live with purpose, dignity and connection. The company reported a significant 18% increase in Underlying EBITDA to $49.0 million, up from $41.5 million in the prior corresponding period. This was achieved despite a notable decrease in reported Total Comprehensive Income, which fell 86.9% to $5.3 million from $40.4 million a year earlier. Encouragingly, Cash Flow from Existing Operations saw a positive turnaround, moving from a $6.6 million outflow to a $0.4 million inflow for the period, reflecting a strategic focus on cash generation.
Operationally, Oceania Healthcare recorded 275 total sales, a 1.5% increase on the previous corresponding period, with resales rising 11% to 200 settlements. New sales contributed 75 units, leading to a 35% reduction in unsold development stock. Care occupancy rates improved to a rolling 12-month average of 93.1%, up 1.2 percentage points, reaching 94.3% as at 30 September 2026. Furthermore, annualised Care Annuity EBITDA per occupied bed/suite increased substantially by 48.1% to $24.4 thousand, underscoring enhanced care margins and operational efficiencies. The company’s total assets rose to $3.13 billion, up from $3.08 billion at 31 March 2026.
In terms of capital management, the company’s gearing ratio strengthened to 29.6%, down from 30.1% at the end of the last fiscal year and comfortably within its 30-35% target range. Net debt decreased by $8.0 million to $498.7 million. Oceania Healthcare successfully completed a $125 million six-year retail bond issue in July 2026, which helped to repay bank debt and diversify funding sources. The development capital expenditure for the period decreased by 33.1% to $27.7 million, with 81 units and care suites planned for completion in the second half of fiscal year 2027. The Board decided not to declare an interim dividend for 1HY27, citing capital priorities, but remains committed to resuming distributions as cash generation builds.
